A Bispecific Biologic That Robustly Reverses HIV-1 and SIV Latency
Antiretroviral therapy suppresses HIV-1 replication but cannot eliminate the latent viral reservoir persisting in memory CD4 T cells. Existing latency reversal candidates have yet to achieve robust viral reactivation at tolerable doses. We engineered T4IL15{triangleup}, a bispecific biologic that selectively delivers IL-15 signaling to memory CD4 T cells, with minimal off-target stimulation.…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
